Ipca Laboratories Ltd Nine-Monthly Results: Standalone & Consolidated Reports

Nine Monthly Results

Results Snapshot

Figures in Cr

Consolidate Nine Monthly Results

Dec'25

Dec'24

Dec'23

Dec'22

Dec'21

Dec'20

Dec'19

Net Sales

7,257.85

6,692.90

5,672.02

4,732.69

4,540.69

4,305.33

3,574.95

Other Operating Income

0.00

Total Operating income

7,257.85

6,692.90

5,672.02

4,732.69

4,540.69

4,305.33

3,574.95

Raw Material Cost

1,751.41

1,616.75

1,651.27

1,295.56

1,252.69

1,179.58

1,082.69

Purchase of Finished goods

383.40

460.80

381.50

398.67

337.84

223.51

274.37

(Increase) / Decrease In Stocks

-3.71

-7.29

-142.91

21.10

-1.89

-13.38

-77.52

Employee Cost

1,627.20

1,483.15

1,242.42

960.31

879.65

755.94

679.05

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,004.86

1,842.21

1,540.48

1,311.32

982.47

844.24

878.12

Total Expenditure (Excl Depreciation)

5,763.16

5,395.62

4,672.76

3,986.96

3,450.76

2,989.89

2,836.71

Operating Profit (PBDIT) excl Other Income

1,494.69

1,297.28

999.26

745.73

1,089.93

1,315.44

738.24

Other Income

80.71

66.98

105.85

89.23

51.40

42.92

53.27

Operating Profit (PBDIT)

1,575.40

1,364.26

1,105.11

834.96

1,141.33

1,358.36

791.51

Interest

55.74

63.42

108.90

27.09

4.31

7.34

12.83

Exceptional Items

-40.61

0.00

28.97

0.00

Gross Profit (PBDT)

1,479.05

1,300.84

1,025.18

807.87

1,137.02

1,351.02

778.68

Depreciation

310.98

297.70

259.11

192.02

171.48

156.67

146.56

Profit Before Tax

1,168.07

1,003.14

766.07

615.85

965.54

1,194.35

632.12

Tax

286.10

281.39

239.77

204.99

196.01

209.21

106.13

Provisions and contingencies

0.00

Profit After Tax

881.97

721.75

526.30

410.86

769.53

985.14

525.99

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

881.97

721.75

526.30

410.86

769.53

985.14

525.99

Share in Profit of Associates

-4.88

-0.50

-4.71

-10.01

-12.35

-5.20

-5.48

Minority Interest

39.76

5.05

48.41

-2.29

-0.40

2.91

-0.34

Other related items

0.00

Consolidated Net Profit

842.05

669.86

487.76

394.80

753.22

978.67

520.31

Equity Capital

25.37

25.27

Face Value

1.0

2.0

Reserves

0.00

Diluted Earnings per share

12.86

9.78

7.09

4.25

7.76

21.09

15.63

Operating Profit Margin (Excl OI)

20.59%

19.38%

17.62%

15.76%

24.0%

30.55%

20.65%

Gross Profit Margin

20.38%

19.44%

18.07%

17.07%

25.04%

31.38%

21.78%

PAT Margin

12.15%

10.78%

9.28%

8.68%

16.95%

22.88%

14.71%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Nine Monthly Analysis Highlights

Net Sales

YoY Growth in nine months ended Dec 2025 is 8.44% vs 18.00% in Dec 2024

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 25.71% vs 37.33% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 15.22% vs 29.82% in Dec 2024

Interest

YoY Growth in nine months ended Dec 2025 is -12.11% vs -41.76% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Ipca Labs With

Select Peers

Figures in Cr

Consolidate Nine Monthly Results

Change(INR)

Change(%)

Net Sales

7,257.85

1,513.39

5,744.46

379.58%

Other Operating Income

0.00

Total Operating income

7,257.85

1,513.39

5,744.46

379.58%

Raw Material Cost

1,751.41

548.39

1,203.02

219.37%

Purchase of Finished goods

383.40

0.00

383.40

(Increase) / Decrease In Stocks

-3.71

48.44

-52.15

-107.66%

Employee Cost

1,627.20

210.23

1,416.97

674.01%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

2,004.86

139.74

1,865.12

1,334.71%

Total Expenditure (Excl Depreciation)

5,763.16

946.80

4,816.36

508.70%

Operating Profit (PBDIT) excl Other Income

1,494.69

566.59

928.10

163.80%

Other Income

80.71

104.57

-23.86

-22.82%

Operating Profit (PBDIT)

1,575.40

671.16

904.24

134.73%

Interest

55.74

4.99

50.75

1,017.03%

Exceptional Items

-40.61

-25.37

-15.24

-60.07%

Gross Profit (PBDT)

1,479.05

640.80

838.25

130.81%

Depreciation

310.98

94.48

216.50

229.15%

Profit Before Tax

1,168.07

546.32

621.75

113.81%

Tax

286.10

144.29

141.81

98.28%

Provisions and contingencies

0.00

Profit After Tax

881.97

402.04

479.93

119.37%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

881.97

402.04

479.93

119.37%

Share in Profit of Associates

-4.88

0.00

-4.88

Minority Interest

39.76

0.00

39.76

Other related items

0.00

Consolidated Net Profit

842.05

402.04

440.01

109.44%

Equity Capital

25.37

112.32

-86.95

-77.41%

Face Value

1.00

2.00

0.00

Reserves

0.00

Gross Profit Margin

20.38%

42.34%

0.00

-21.96%

PAT Margin

12.15%

26.57%

0.00

-14.42%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Nine Monthly - Net Sales

Net Sales 7,257.85 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 8.44% vs 18.00% in Dec 2024

Nine Monthly - Consolidate Net Profit

Consolidate Net Profit 842.05 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 25.71% vs 37.33% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 1,494.69 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is 15.22% vs 29.82% in Dec 2024

Nine Monthly - Interest

Interest 55.74 Cr

in Dec 2025

Figures in Cr

YoY Growth in nine months ended Dec 2025 is -12.11% vs -41.76% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 20.59%

in Dec 2025

Figures in %

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024